Results 1-175 of 175 (Search time: 0.019 seconds).

Issue DateTitleAuthor(s)SourcescopusWOSFulltext/Archive link
12024Administration mode matters for 5‐fluorouracil therapy: Physiologically based pharmacokinetic evidence for avoidance of myelotoxicity by continuous infusion but not intravenous bolusChao, Chih‐Jia; Gardner, Iain; CHUN-JUNG LIN ; KUN-HUEI YEH ; Lu, Wan‐Chen; Abduljalil, Khaled; YUNN-FANG HO British Journal of Clinical Pharmacology
22023Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12CFakih, Marwan G; Salvatore, Lisa; Esaki, Taito; Modest, Dominik P; Lopez-Bravo, David P; Taieb, Julien; Karamouzis, Michalis V; Ruiz-Garcia, Erika; Kim, Tae-Won; Kuboki, Yasutoshi; Meriggi, Fausto; Cunningham, David; KUN-HUEI YEH ; Chan, Emily; Chao, Joseph; Saportas, Yaneth; Tran, Qui; Cremolini, Chiara; Pietrantonio, FilippoThe New England journal of medicine35
32023Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trialRha, Sun Young; Oh, Do-Youn; Yañez, Patricio; Bai, Yuxian; Ryu, Min-Hee; Lee, Jeeyun; Rivera, Fernando; Alves, Gustavo Vasconcelos; Garrido, Marcelo; Shiu, Kai-Keen; Fernández, Manuel González; Li, Jin; Lowery, Maeve A; Çil, Timuçin; Cruz, Felipe Melo; Qin, Shukui; Luo, Suxia; Pan, Hongming; Wainberg, Zev A; Yin, Lina; Bordia, Sonal; Bhagia, Pooja; Wyrwicz, Lucjan S; KUN-HUEI YEH The Lancet. Oncology21
42023Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancerYoshino, T; Cervantes, A; Bando, H; Martinelli, E; Oki, E; Xu, R-H; Mulansari, N A; Govind Babu, K; Lee, M A; Tan, C K; Cornelio, G; Chong, D Q; Chen, L-T; Tanasanvimon, S; Prasongsook, N; KUN-HUEI YEH ; Chua, C; Sacdalan, M D; Sow Jenson, W J; Kim, S T; Chacko, R T; Syaiful, R A; Zhang, S Z; Curigliano, G; Mishima, S; Nakamura, Y; Ebi, H; Sunakawa, Y; Takahashi, M; Baba, E; Peters, S; Ishioka, C; Pentheroudakis, GESMO open93
52023Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE)Ryu, Min-Hee; Lee, Kyung Hee; Shen, Lin; KUN-HUEI YEH ; Yoo, Changhoon; Hong, Young Seon; Park, Young Iee; Yang, Sung Hyun; Shin, Dong Bok; Zang, Dae Young; Kang, Won Ki; Chung, Ik-Joo; Kim, Yeul Hong; Ryoo, Baek-Yeol; Nam, Byung-Ho; Park, Young Soo; Kang, Yoon-KooCancer medicine41
62023Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062Satake, Hironaga; Lee, Keun-Wook; Chung, Hyun Cheol; Lee, Jeeyun; Yamaguchi, Kensei; Chen, Jen-Shi; Yoshikawa, Takaki; Amagai, Kenji; KUN-HUEI YEH ; Goto, Masahiro; Chao, Yee; Lam, Ka-On; Han, Shi Rong; Shiratori, Shinichi; Shah, Sukrut; Shitara, KoheiJapanese journal of clinical oncology10
72023Novel prognostic implications of complement activation in the tumour microenvironment for de novo metastatic BRAF V600E mutant colorectal cancerKUO-HSING CHEN ; CHIA-LANG HSU ; Su, Yu-Li; CHANG-TSU YUAN ; LIANG-IN LIN ; JIA-HUEI TSAI ; YI-HSIN LIANG ; ANN-LII CHENG ; KUN-HUEI YEH British journal of cancer00
82022Ramucirumab plus triplet chemotherapy as an alternative salvage treatment for patients with metastatic colorectal cancerYI-HSIN LIANG ; JIN-TUNG LIANG ; BEEN-REN LIN ; JOHN HUANG ; JI-SHIANG HUNG ; SHUO-LUN LAI ; TZU-CHUN CHEN ; JIA-HUEI TSAI ; Cheng, Yung-Ming; Tsao, Ting-Han; Hsu, Wen-Ling; KUO-HSING CHEN ; KUN-HUEI YEH Journal of the Formosan Medical Association = Taiwan yi zhi32
92022Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue LymphomaSUNG-HSIN KUO ; KUN-HUEI YEH ; CHUNG-WU LIN ; JYH-MING LIOU ; MING-SHIANG WU ; Chen, Li-Tzong; ANN-LII CHENG Cancers98
102022A pilot study of metabolomic pathways associated with fatigue in patients with colorectal cancer receiving chemotherapyChou, Yun-Jen; Kober, Kord M; KUN-HUEI YEH ; Cooper, Bruce A; CHING-HUA KUO ; BEEN-REN LIN ; Kuo, Tien-Chueh; Miaskowski, Christine; YUFENG JANE TSENG European journal of oncology nursing : the official journal of European Oncology Nursing Society31
112022Spectrum of cancer patients receiving renal biopsyFAN-CHI CHANG ; WEI-WU CHEN ; TAO-MIN HUANG ; WEI-CHOU LIN ; Liu, Jia-Sin; WEN-CHIH CHIANG ; YUNG-MING CHEN ; CHIUN HSU ; KUN-HUEI YEH ; TZONG-SHINN CHU Journal of the Formosan Medical Association = Taiwan yi zhi10
122022Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 studyKang Y.-K.; Morita S.; Satoh T.; Ryu M.-H.; Chao Y.; Kato K.; Chung H.C.; Chen J.-S.; Muro K.; Kang W.K.; KUN-HUEI YEH ; Yoshikawa T.; Oh S.C.; Bai L.-Y.; Tamura T.; Lee K.-W.; Hamamoto Y.; Kim J.G.; Chin K.; Oh D.-Y.; Minashi K.; Cho J.Y.; Tsuda M.; Sameshima H.; Chen L.-T.; Boku N.Gastric Cancer87
132021Proteasome inhibitors restore the STAT1 pathway and enhance the expression of MHC class I on human colon cancer cellsYI-HSIN LIANG ; KUO-HSING CHEN ; JIA-HUEI TSAI ; Cheng, Yung-Ming; Lee, Chang-Cheng; Kao, Chiu-Hwa; Chan, Kuang-Yu; Chen, Yeh-Ting; Hsu, Wen-Ling; KUN-HUEI YEH Journal of biomedical science76
142021Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-κB-related signalingSUNG-HSIN KUO ; SHIH-HUNG YANG ; Wei, Ming-Feng; Lee, Hsiao-Wei; YU-WEN TIEN ; ANN-LII CHENG ; KUN-HUEI YEH Cancer cell international33
152021Association between risk factors, molecular features and CpG island methylator phenotype colorectal cancer among different age groups in a Taiwanese cohortKUO-HSING CHEN ; LIANG-IN LIN ; CHANG-TSU YUAN ; LI-HUI TSENG ; Chao, Yu-Liang; YI-HSIN LIANG ; JIN-TUNG LIANG ; BEEN-REN LIN ; ANN-LII CHENG ; KUN-HUEI YEH British journal of cancer00
162021Real-world evidence of the safety and effectiveness of regorafenib in Taiwanese patients with metastatic colorectal cancer: CORRELATE TaiwanKUN-HUEI YEH ; Yang T.-S.; Hsu T.-C.; Tzu-Liang Chen W.; Chen H.-H.; Teng H.-W.; Lin B.-W.; Kuan F.-C.; Chiang F.-F.; Duann C.-W.; Li Y.-S.; Lin M.-T.; Fiala-Buskies S.; Ducreux M.; Wang J.-Y.Journal of the Formosan Medical Association32
172021Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancerYoshino T.; Argil?s G.; Oki E.; Martinelli E.; Taniguchi H.; Arnold D.; Mishima S.; Li Y.; Smruti B.K.; Ahn J.B.; Faud I.; Chee C.E.; KUN-HUEI YEH ; Lin P.-C.; Chua C.; Hasbullah H.H.; Lee M.A.; Sharma A.; Sun Y.; Curigliano G.; Bando H.; Lordick F.; Yamanaka T.; Tabernero J.; Baba E.; Cervantes A.; Ohtsu A.; Peters S.; Ishioka C.; Pentheroudakis G.Annals of Oncology4236
182021Chemotherapy agents stimulate dendritic cells against human colon cancer cells through upregulation of the transporter associated with antigen processingYI-HSIN LIANG ; JIA-HUEI TSAI ; Cheng Y.-M.; Chan K.-Y.; Hsu W.-L.; Lee C.-C.; KUO-HSING CHEN ; KUN-HUEI YEH Scientific reports63
192021Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumabBoku N.; Satoh T.; Ryu M.-H.; Chao Y.; Kato K.; Chung H.C.; Chen J.-S.; Muro K.; Kang W.K.; KUN-HUEI YEH ; Yoshikawa T.; Oh S.C.; Bai L.-Y.; Tamura T.; Lee K.-W.; Hamamoto Y.; Kim J.G.; Chin K.; Oh D.-Y.; Minashi K.; Cho J.Y.; Tsuda M.; Nishiyama T.; Chen L.-T.; Kang Y.-K.Gastric Cancer5043
202021Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinomaSHIH-HUNG YANG ; LI-CHUN LU ; HSIANG-FONG KAO ; BANG-BIN CHEN ; TING-CHUN KUO ; SUNG-HSIN KUO ; YU-WEN TIEN ; Bai, Li-Yuan; ANN-LII CHENG ; KUN-HUEI YEH Oncoimmunology34
212021Comparison of clinicopathological features and treatment outcomes in aggressive primary intestinal B- and T/NK-cell lymphomasWEI-LI MA ; KUN-HUEI YEH ; MING YAO ; JIH-LUH TANG ; CHUNG-WU LIN ; Wang Y.-T.; Yeh Y.-C.; HSIU-PO WANG ; ANN-LII CHENG ; SUNG-HSIN KUO Journal of the Formosan Medical Association53
222021A Pilot Study of Metabolomic Pathways Associated With Fatigue in Survivors of Colorectal CancerChou, Y.-J.; Kober, K.M.; CHING-HUA KUO ; KUN-HUEI YEH ; Kuo, T.-C.; Tseng, Y.J.; Miaskowski, C.; JIN-TUNG LIANG ; YUFENG JANE TSENG Biological Research for Nursing96
232020A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update dataChen L.-T.; Satoh T.; Ryu M.-H.; Chao Y.; Kato K.; Chung H.C.; Chen J.-S.; Muro K.; Kang W.K.; KUN-HUEI YEH ; Yoshikawa T.; Oh S.C.; Bai L.-Y.; Tamura T.; Lee K.-W.; Hamamoto Y.; Kim J.G.; Chin K.; Oh D.-Y.; Minashi K.; Cho J.Y.; Tsuda M.; Sameshima H.; Kang Y.-K.; Boku N.Gastric Cancer138130
242020A nationwide survey of fatigue in cancer patients in Taiwan: An unmet needRau K.-M.; Rau K.-M.; SHIOW-CHING SHUN ; Chiou T.-J.; Lu C.-H.; Lu C.-H.; Ko W.-H.; Ko W.-H.; Lee M.-Y.; Huang W.-T.; KUN-HUEI YEH ; Chang C.-S.; Chang C.-S.; Hsieh R.-K.Japanese Journal of Clinical Oncology99
252020Complement C1q mediates the expansion of periportal hepatic progenitor cells in senescence-associated inflammatory liverHo T.-C.; Wang E.-Y.; KUN-HUEI YEH ; YUNG-MING JENG ; Horng J.-H.; Wu L.-L.; Chen Y.-T.; Huang H.-C.; CHIA-LANG HSU ; PEI-JER CHEN ; Shiou-Hwei Yeh ; DING-SHINN CHEN Proceedings of the National Academy of Sciences of the United States of America109
262020Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patientsSHIH-HUNG YANG ; JHE-CYUAN GUO ; CHIUN HSU ; SUNG-HSIN KUO ; YU-WEN TIEN ; ANN-LII CHENG ; KUN-HUEI YEH Journal of the Formosan Medical Association33
272020Regorafenib in Chinese patients with metastatic colorectal cancer: Subgroup analysis of the phase 3 CONCUR trialXu J.; Xu R.-H.; Qin S.; Pan H.; Bai Y.; Chi Y.; Wang L.; Bi F.; Cheng Y.; Liu T.; Ma D.; Shen L.; Ba Y.; Liang J.; Wang X.; Yau T.C.C.; Ma B.B.; KUN-HUEI YEH ; Lin J.-K.; Kappeler C.; Shapiro J.; Kalmus J.; Li J.Journal of Gastroenterology and Hepatology (Australia)75
282020A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissueTsai H.-J.; Tai J.J.; Chen L.-T.; MING-SHIANG WU ; KUN-HUEI YEH ; CHUNG-WU LIN ; Wang T.-E.; HSIU-PO WANG ; Yu F.-J.; JYH-MING LIOU ; Hsiao C.-F.; TSU-YAO CHENG ; Yeh H.-J.; Ko C.-W.; Chen M.-J.; Lo G.-H.; Hsu P.-I.; Chang C.-S.; Hwang W.-S.; Chuang S.-S.; Lee H.-W.; CHIA-TUNG SHUN ; Chiu C.-F.; Wang W.-M.; Hsieh C.-Y.; Liu T.-W.; Lin J.-T.; SUNG-HSIN KUO ; ANN-LII CHENG Haematologica55
292020Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancerSatoh T.; Kang Y.-K.; Chao Y.; Ryu M.-H.; Kato K.; Cheol Chung H.; Chen J.-S.; Muro K.; Ki Kang W.; KUN-HUEI YEH ; Yoshikawa T.; Oh S.C.; Bai L.-Y.; Tamura T.; Lee K.-W.; Hamamoto Y.; Kim J.G.; Chin K.; Oh D.-Y.; Minashi K.; Cho J.Y.; Tsuda M.; Tanimoto M.; Chen L.-T.; Boku N.Gastric Cancer4339
302020JSCO—ESMO—ASCO—JSMO—TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusionsYoshino T.; Pentheroudakis G.; Mishima S.; Overman M.J.; KUN-HUEI YEH ; Baba E.; Naito Y.; Calvo F.; Saxena A.; Chen L.-T.; Takeda M.; Cervantes A.; Taniguchi H.; Yoshida K.; Kodera Y.; Kitagawa Y.; Tabernero J.; Burris H.; Douillard J.-Y.Annals of Oncology8965
312019Novel insights of lymphomagenesis of helicobacter pylori-dependent gastric mucosa-associated lymphoid tissue lymphomaSUNG-HSIN KUO ; MING-SHIANG WU ; KUN-HUEI YEH ; CHUNG-WU LIN ; PING-NING HSU ; Chen L.-T.; ANN-LII CHENG Cancers2122
322019Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: A JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOSMuro K.; Van Cutsem E.; Narita Y.; Pentheroudakis G.; Baba E.; Li J.; Ryu M.-H.; Wan Zamaniah W.I.; Yong W.-P.; KUN-HUEI YEH ; Kato K.; Lu Z.; Cho B.C.; Nor I.M.; Ng M.; Chen L.-T.; Nakajima T.E.; Shitara K.; Kawakami H.; Tsushima T.; Yoshino T.; Lordick F.; Martinelli E.; Smyth E.C.; Arnold D.; Minami H.; Tabernero J.; Douillard J.-Y.Annals of Oncology164147
332019CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal CancerKUO-HSING CHEN ; LIANG-IN LIN ; LI-HUI TSENG ; Lin, Yu-Lin; JAU-YU LIAU ; JIA-HUEI TSAI ; JIN-TUNG LIANG ; BEEN-REN LIN ; ANN-LII CHENG ; KUN-HUEI YEH Oncology64
342019Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: A JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOSMuro K.; Lordick F.; Tsushima T.; Pentheroudakis G.; Baba E.; Lu Z.; Cho B.C.; Nor I.M.; Ng M.; Chen L.-T.; Kato K.; Li J.; Ryu M.-H.; Wan Zamaniah W.I.; Yong W.-P.; KUN-HUEI YEH ; Nakajima T.E.; Shitara K.; Kawakami H.; Narita Y.; Yoshino T.; Van Cutsem E.; Martinelli E.; Smyth E.C.; Arnold D.; Minami H.; Tabernero J.; Douillard J.-Y.Annals of Oncology10490
352019Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinomaTa-Chen Huang ; CHIA-CHI LIN ; Wu Y.-C.; CHIA-HSIEN CHENG ; JANG-MING LEE ; HSIU-PO WANG ; PEI-MING HUANG ; Feng-Ming Hsu ; KUN-HUEI YEH ; ANN-LII CHENG ; KAI-YUAN TZEN ; CHIH-HUNG HSU Journal of the Formosan Medical Association86
362018A Phase i study of S-1-based concurrent chemoradiotherapy followed by gemcitabine and S-1 in metastatic pancreatic adenocarcinomaSHIH-HUNG YANG ; YU-YUN SHAO ; CHIA-CHI LIN ; SUNG-HSIN KUO ; ANN-LII CHENG ; KUN-HUEI YEH Anticancer Research32
372018Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYnote-061): a randomised, open-label, controlled, phase 3 trialShitara K.; ?zg?ro?lu M.; Bang Y.-J.; Di Bartolomeo M.; Mandal? M.; Ryu M.-H.; Fornaro L.; Olesi?ski T.; Caglevic C.; Chung H.C.; Muro K.; Goekkurt E.; Mansoor W.; McDermott R.S.; Shacham-Shmueli E.; Chen X.; Mayo C.; Kang S.P.; Ohtsu A.; Fuchs C.S.; Lerzo G.; O'Connor J.M.; Mendez G.A.; Lynam J.; Tebbutt N.; Wong M.; Strickland A.; Karapetis C.; Goldstein D.; Vasey P.; Van Laethem J.-L.; Van Cutsem E.; Berry S.; Vincent M.; Muller B.; Rey F.; Zambrano A.; Guerra J.; Krogh M.; Baeksgaard L.; Yilmaz M.; Elme A.; Magi A.; Auvinen P.; Alanko T.; Moehler M.; Kunzmann V.; Seufferlein T.; Thuss-Patience P.; Goekkurt E.; Hoehler T.; Haag G.; Al-Batran S.-E.; Castro H.; Lopez K.; Aguilar Vasquez M.; Sandoval M.; Lam K.O.; Cuffe S.; Kelly C.; Geva R.; Shacham-Shmueli E.; Hubert A.; Beny A.; Brenner B.; Giuseppe A.; Falcone A.; Maiello E.; Passalacqua R.; Montesarchio V.; Hara H.; Chin K.; Nishina T.; Komatsu Y.; Machida N.; Hironaka S.; Satoh T.; Tamura T.; Sugimoto N.; Cho H.; Omuro Y.; Kato K.; Goto M.; Hyodo I.; Yoshida K.; Baba H.; Esaki T.; Furuse J.; Wan Mohammed W.Z.; Hernandez Hernandez C.; Casas Garcia J.; Dominguez Andrade A.; Clarke K.; Hjortland G.; Glenjen N.; Kubiatowski T.; Jacek J.; Wojtukiewicz M.; Lazarev S.; Lancukhay Y.; Afanasayev S.; Moiseyenko V.; Kostorov V.; Protsenko S.; Shirinkin V.; Sakaeva D.; Fadeeva N.; Yong W.P.; Ng C.H.M.; Robertson B.; Rapaport B.; Cohen G.; Dreosti L.; Ruff P.; Jacobs C.; Landers G.; Szpak W.; Roh S.-Y.; Lee J.; Kim Y.H.; Bang Y.-J.; Chung H.C.; Ryu M.-H.; Alsina Maqueda M.; Longo Munoz F.; Cervantes Aguilar A.; Aranda Aguilar E.; Garcia Alfonso P.; Rivera F.; Feliu Batle J.; Pazo Cid R.; KUN-HUEI YEH ; Chen J.-S.; Chao Y.; Yen C.-J.; ?zg?ro?lu M.; Kara O.; Yalcin S.; Hochhauser D.; Chau I.; Benson A.; Shankaran V.; Shaib W.; Philip P.; Sharma V.; Siegel R.; Sun W.; Wainberg Z.; George B.; Bullock A.; Myrick S.; Faruol J.; Siegel R.; Larson T.; Becerra C.; Ratnam S.; Richards D.A.; Riche S.L.; KEYnote-061 investigatorsThe Lancet946844
382018Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: A JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOSYoshino T.; Arnold D.; Taniguchi H.; Pentheroudakis G.; Yamazaki K.; Xu R.-H.; Kim T.W.; Ismail F.; Tan I.B.; KUN-HUEI YEH ; Grothey A.; Zhang S.; Ahn J.B.; Mastura M.Y.; Chong D.; Chen L.-T.; Kopetz S.; Eguchi-Nakajima T.; Ebi H.; Ohtsu A.; Cervantes A.; Muro K.; Tabernero J.; Minami H.; Ciardiello F.; Douillard J.-Y.Annals of Oncology433383
392018Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapyJHE-CYUAN GUO ; CHIA-CHI LIN ; Ta-Chen Huang ; PEI-MING HUANG ; HUNG-YANG KUO ; Chang C.-H.; CHIA-CHUN WANG ; CHIA-HSIEN CHENG ; KUN-HUEI YEH ; CHIH-HUNG HSU ; JANG-MING LEE Anticancer Research1211
402018Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: A randomized Phase III studyLi J.; Xu R.; Qin S.; Liu T.; Pan H.; Xu J.; Bi F.; Lim R.; Zhang S.; Ba Y.; Bai Y.; Fan N.; Tsuji A.; KUN-HUEI YEH ; Ma B.; Wei V.; Shi D.; Magherini E.; Shen L.Future Oncology2116
412018Phase II study of BGJ398 in patients with FGFR-Altered advanced cholangiocarcinomaJavle M.; Lowery M.; Shroff R.T.; Weiss K.H.; Springfeld C.; Borad M.J.; Ramanathan R.K.; Goyal L.; Sadeghi S.; Macarulla T.; El-Khoueiry A.; Kelley R.K.; Borbath I.; Choo S.P.; Oh D.-Y.; Philip P.A.; Chen L.-T.; Reungwetwattana T.; Van Cutsem E.; KUN-HUEI YEH ; Ciombor K.; Finn R.S.; Patel A.; Sen S.; Porter D.; Isaacs R.; Zhu A.X.; Abou-Alfa G.K.; Bekaii-Saab T.Journal of Clinical Oncology513428
422017Irinotecan and oxaliplatin might provide equal benefit as adjuvant chemotherapy for patients with resectable synchronous colon cancer and liver-confined metastases: A nationwide database studyYI-HSIN LIANG ; YU-YUN SHAO ; Chen, Ho Min; ANN-LII CHENG ; Lai, Mei Shu; KUN-HUEI YEH Anticancer Research1011
432017Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric CancerTsai K.-F.; JYH-MING LIOU ; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; SUNG-HSIN KUO ; I-RUE LAI ; KUN-HUEI YEH ; MING-TSAN LIN ; HSIU-PO WANG ; ANN-LII CHENG ; Lin J.-T.; CHIA-TUNG SHUN ; MING-SHIANG WU PLoS ONE2925
442017Anti-angiogenic therapy in patients with advanced gastric and gastroesophageal junction cancer: A systematic reviewChen L.-T.; Oh D.-Y.; Ryu M.-H.; KUN-HUEI YEH ; Yeo W.; Carlesi R.; Cheng R.; Kim J.; Orlando M.; Kang Y.-K.Cancer Research and Treatment5443
452017First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphomaSUNG-HSIN KUO ; KUN-HUEI YEH ; MING-SHIANG WU ; CHUNG-WU LIN ; Wei M.-F.; JYH-MING LIOU ; HSIU-PO WANG ; Chen L.-T.; ANN-LII CHENG Scientific Reports1718
462017The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21)SUNG-HSIN KUO ; Tsai H.-J.; CHUNG-WU LIN ; KUN-HUEI YEH ; Lee H.-W.; Wei M.-F.; CHIA-TUNG SHUN ; MING-SHIANG WU ; PING-NING HSU ; Chen L.-T.; ANN-LII CHENG Journal of Pathology1212
472017Computed tomographic characteristics for patients with unresectable gastric cancer harboring low-volume peritoneal carcinomatosisJHE-CYUAN GUO ; CHIN-CHEN CHANG ; Yang C.-Y.; BIN-CHI LIAO ; JAU-YU LIAU ; Chang C.-H.; KUN-HUEI YEH Medical Oncology53
482017Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCLSUNG-HSIN KUO ; Chen L.-T.; CHUNG-WU LIN ; KUN-HUEI YEH ; CHIA-TUNG SHUN ; Tzeng Y.-S.; JYH-MING LIOU ; MING-SHIANG WU ; PING-NING HSU ; ANN-LII CHENG Blood2016
492017Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC StudyANN-LII CHENG ; Cornelio G.; Shen L.; Price T.; Yang T.-S.; Chung I.J.; Dai G.-H.; Lin J.-K.; Sharma A.; KUN-HUEI YEH ; Ma B.; Zaatar A.; Guan Z.; Masood N.; Srimuninnimit V.; Yau T.; Gibbs P.; Wang X.; Doval D.C.; Oh S.-T.; Shim B.Y.; Gorospe C.; Wang H.-M.; Sirachainan E.; Hill A.; Suh K.W.; Beier F.; Chatterjee S.; Lim R.Clinical Colorectal Cancer2119
502017Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancerYI-HSIN LIANG ; Wei, C. H.; Hsu, W. H.; YU-YUN SHAO ; Lin, Y. C.; Chou, P. C.; ANN-LII CHENG ; KUN-HUEI YEH Support Care Cancer1010
512017Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trialKang Y.-K.; Boku N.; Satoh T.; Ryu M.-H.; Chao Y.; Kato K.; Chung H.C.; Chen J.-S.; Muro K.; Kang W.K.; KUN-HUEI YEH ; Yoshikawa T.; Oh S.C.; Bai L.-Y.; Tamura T.; Lee K.-W.; Hamamoto Y.; Kim J.G.; Chin K.; Oh D.-Y.; Minashi K.; Cho J.Y.; Tsuda M.; Chen L.-T.The Lancet16661458
522017Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapySHIH-HUNG YANG ; JEN-CHIEH LEE ; JHE-CYUAN GUO ; SUNG-HSIN KUO ; YU-WEN TIEN ; TING-CHUN KUO ; ANN-LII CHENG ; KUN-HUEI YEH PLoS ONE63
532016Case report: Mismatch repair proficiency and microsatellite stability in gastric cancer may not predict programmed death-1 blockade resistanceKUO-HSING CHEN ; CHANG-TSU YUAN ; LI-HUI TSENG ; CHIA-TUNG SHUN ; KUN-HUEI YEH Journal of Hematology and Oncology1917
542016Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancerSHIH-HUNG YANG ; TING-CHUN KUO ; Wu H.; JHE-CYUAN GUO ; CHIUN HSU ; CHIH-HUNG HSU ; YU-WEN TIEN ; KUN-HUEI YEH ; ANN-LII CHENG ; SUNG-HSIN KUO World Journal of Gastroenterology2425
552016Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancerSHIH-HUNG YANG ; JHE-CYUAN GUO ; KUN-HUEI YEH ; YU-WEN TIEN ; ANN-LII CHENG ; SUNG-HSIN KUO Journal of Gastroenterology and Hepatology (Australia)77
562016BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancerKUO-HSING CHEN ; Lin Y.-L.; JAU-YU LIAU ; JIA-HUEI TSAI ; LI-HUI TSENG ; LIANG-IN LIN ; JIN-TUNG LIANG ; BEEN-REN LIN ; JI-SHIANG HUNG ; YIH-LEONG CHANG ; KUN-HUEI YEH ; ANN-LII CHENG Medical Oncology1918
572016Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: Association with distinct clinicopathological and molecular features and poor clinical outcomeJIA-HUEI TSAI ; JAU-YU LIAU ; Lin Y.-L.; LI-HUI TSENG ; LIANG-IN LIN ; KUN-HUEI YEH ; YUNG-MING JENG Journal of Clinical Pathology66
582016Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: A nationwide cohort studyKUO-HSING CHEN ; YU-YUN SHAO ; Chen H.-M.; Lin Y.-L.; ZHONG-ZHE LIN ; Lai M.-S.; ANN-LII CHENG ; KUN-HUEI YEH BMC Cancer4139
592016Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic miceLin W.-H.; Shiou-Hwei Yeh ; KUN-HUEI YEH ; Chen K.-W.; Cheng Y.-W.; TUNG-HUNG SU ; Jao P.; Ni L.-C.; PEI-JER CHEN ; Chen D.-S.Proceedings of the National Academy of Sciences of the United States of America3734
602015Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): A randomised, double-blind, placebo-controlled, phase 3 trialLi J.; Qin S.; Xu R.; Yau T.C.C.; Ma B.; Pan H.; Xu J.; Bai Y.; Chi Y.; Wang L.; KUN-HUEI YEH ; Bi F.; Cheng Y.; Le A.T.; Lin J.-K.; Liu T.; Ma D.; Kappeler C.; Kalmus J.; Kim T.W.The Lancet Oncology597536
612015Phase i study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patientsChang T.C.; Shiah H.S.; CHIH-HSIN YANG ; KUN-HUEI YEH ; ANN-LII CHENG ; Shen B.N.; Wang Y.W.; Yeh C.G.; Chiang N.J.; Chang J.Y.; Chen L.T.Cancer Chemotherapy and Pharmacology8774
622015Gemcitabine plus cisplatin for patients with recurrent or metastatic nasopharyngeal carcinoma in Taiwan: A multicenter prospective Phase II trialHsieh J.C.; Hsu C.-L.; Ng S.-H.; Wang C.-H.; Lee K.-D.; Lu C.-H.; Chang Y.-F.; Hsieh R.-K.; KUN-HUEI YEH ; Hsiao C.-H.; Chen S.-Y.; Shiau C.-Y.; Wang H.-M.Japanese Journal of Clinical Oncology1819
632015Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinomaLi C.-L.; KUN-HUEI YEH ; Liu W.-H.; CHI-LING CHEN ; DING-SHINN CHEN ; PEI-JER CHEN ; Shiou-Hwei Yeh International Journal of Cancer3935
642015Helicobacter pylori CagA translocation is closely associated with the expression of caga-signaling molecules in low-grade gastric mucosa-associated lymphoid tissue lymphomaSUNG-HSIN KUO ; KUN-HUEI YEH ; Chen L.-T.; CHUNG-WU LIN ; PING-NING HSU ; MING-SHIANG WU ; JYH-MING LIOU ; Tsai H.-J.; Tzeng Y.-S.; ANN-LII CHENG American Journal of Surgical Pathology1616
652015Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutationsYI-HSIN LIANG ; Lin Y.-L.; JAU-YU LIAU ; JIA-HUEI TSAI ; JIN-TUNG LIANG ; BEEN-REN LIN ; JI-SHIANG HUNG ; LI-HUI TSENG ; LIANG-IN LIN ; YIH-LEONG CHANG ; ANN-LII CHENG ; KUN-HUEI YEH Anticancer Research44
662015Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinomaJHE-CYUAN GUO ; Ta-Chen Huang ; CHIA-CHI LIN ; MIN-SHU HSIEH ; Chang C.-H.; PEI-MING HUANG ; JANG-MING LEE ; Feng-Ming Hsu ; CHIA-HSIEN CHENG ; HSIU-PO WANG ; KUN-HUEI YEH ; ANN-LII CHENG ; CHIH-HUNG HSU Journal of Thoracic Oncology1516
672015Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in TaiwanYU-YUN SHAO ; CHIH-HUNG HSU ; KUN-HUEI YEH ; Chen H.-M.; Yeh Y.-C.; Lai C.-L.; ZHONG-ZHE LIN ; ANN-LII CHENG ; Lai M.-S.Clinical Colorectal Cancer3532
682015Young patients with colorectal cancer have increased risk of second primary cancersYI-HSIN LIANG ; YU-YUN SHAO ; Chen H.-M.; Lai C.-L.; ZHONG-ZHE LIN ; Kuo R.N.; ANN-LII CHENG ; KUN-HUEI YEH ; Lai M.-S.Japanese Journal of Clinical Oncology1211
692014Unmet supportive care needs of patients with colorectal cancer: Significant differences by type D personalitySHIOW-CHING SHUN ; KUN-HUEI YEH ; JIN-TUNG LIANG ; JOHN HUANG ; SHING-CHIA CHEN ; BEEN-REN LIN ; Lee P.-H.; YEUR-HUR LAI Oncology Nursing Forum2221
702014A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignanciesCHIA-CHI LIN ; Su W.-C.; Yen C.-J.; CHIH-HUNG HSU ; Su W.-P.; KUN-HUEI YEH ; YEN-SHEN LU ; ANN-LII CHENG ; Huang D.C.-L.; Fritsch H.; Voss F.; Taube T.; CHIH-HSIN YANG British Journal of Cancer6364
712014A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancerChao Y.; Hsieh J.-S.; Yeh H.-T.; Su Y.-C.; Wu C.-C.; Chen J.-S.; Tai C.-J.; Bai L.-Y.; KUN-HUEI YEH ; Su W.-C.; Li C.-P.Cancer Chemotherapy and Pharmacology129
722014Beware imposters: MA-1, a novel MALT lymphoma cell line, is misidentified and corresponds to Pfeiffer, a diffuse large B-cell lymphoma cell line-A reply: Despite the same 8-code STR, MA-1 and Pfeiffer are cytogenetically diverseSUNG-HSIN KUO ; Tsai H.-J.; Weng W.-H.; Li C.-C.; KUN-HUEI YEH ; Chen L.-T.; ANN-LII CHENG Genes Chromosomes and Cancer33
732014Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancersHSIANG-FONG KAO ; I-CHUN CHEN ; CHIUN HSU ; Chang S.-Y.; Chien S.-F.; YEE-CHUN CHEN ; Hu F.-C.; CHIH-HSIN YANG ; ANN-LII CHENG ; KUN-HUEI YEH Supportive Care in Cancer1010
742014Molecular-targeted therapy for chemotherapy-refractory gastric cancer: A case report and literature reviewHUNG-YANG KUO ; KUN-HUEI YEH Anticancer Research85
752014Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancerYing-Chun Shen ; Li C.-P.; Yen C.-J.; CHIUN HSU ; Lin Y.-L.; ZHONG-ZHE LIN ; Chen L.-T.; Su W.-C.; Chao Y.; KUN-HUEI YEH ; ANN-LII CHENG Oncology (Switzerland)1512
762014Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: A distinct entity with lower aggressiveness and higher chemosensitivitySUNG-HSIN KUO ; KUN-HUEI YEH ; Chen L.-T.; CHUNG-WU LIN ; PING-NING HSU ; CHIUN HSU ; MING-SHIANG WU ; Tzeng Y.-S.; Tsai H.-J.; HSIU-PO WANG ; ANN-LII CHENG Blood Cancer Journal3432
772014Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patientsLin Y.-.; YI-HSIN LIANG ; JIA-HUEI TSAI ; JAU-YU LIAU ; JIN-TUNG LIANG ; BEEN-REN LIN ; JI-SHIANG HUNG ; LIANG-IN LIN ; LI-HUI TSENG ; YIH-LEONG CHANG ; KUN-HUEI YEH ; ANN-LII CHENG PLoS ONE1716
782014Type 2 diabetes mellitus is associated with increased mortality in chinese patients receiving curative surgery for colon cancerKUO-HSING CHEN ; YU-YUN SHAO ; ZHONG-ZHE LIN ; Yeh Y.-C.; Wen-Yi S.; Kuo R.N.; Chen H.-M.; Lai C.-L.; KUN-HUEI YEH ; ANN-LII CHENG ; Lai M.-S.Oncologist2419
792014Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN - A randomized, phase III studySatoh T.; Doi T.; Ohtsu A.; Tsuji A.; Omuro Y.; Mukaiyama A.; Kobayashi M.; Miwa H.; Xu R.-H.; Sun G.-P.; Xu J.-M.; Wang J.-W.; Li J.; Qin S.-K.; Feng J.-F.; Chung H.C.; Bang Y.-J.; Chung I.-J.; KUN-HUEI YEH Journal of Clinical Oncology528467
802013Oxaliplatin-based Chemotherapy Might Provide Longer Progression-Free Survival in KRAS Mutant Metastatic Colorectal CancerLin, Yu-Lin; JAU-YU LIAU ; SHAN-CHI YU ; LI-HUI TSENG ; LIANG-IN LIN ; JIN-TUNG LIANG ; BEEN-REN LIN ; JI-SHIANG HUNG ; YIH-LEONG CHANG ; KUN-HUEI YEH ; ANN-LII CHENG Translational oncology910
812013erratum: Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression (Gastric Cancer (2012) 15(265-280) DOI 10.1007/s10120-011- 0106-5)CHIUN HSU ; Ying-Chun Shen ; Cheng C.-C.; ANN-LII CHENG ; Hu F.-C.; KUN-HUEI YEH Gastric Cancer00
822013Everolimus for previously treated advanced gastric cancer: Results of the randomized, double-blind, phase III GRANITE-1 studyOhtsu A.; Ajani J.A.; Bai Y.-X.; Bang Y.-J.; Chung H.-C.; Pan H.-M.; Sahmoud T.; Shen L.; KUN-HUEI YEH ; Chin K.; Muro K.; Kim Y.H.; Ferry D.; Tebbutt N.C.; Al-Batran S.-E.; Smith H.; Costantini C.; Rizvi S.; Lebwohl D.; Van Cutsem E.Journal of Clinical Oncology402371
832013Management of gastric cancer in Asia: Resource-stratified guidelinesShen L.; Shan Y.-S.; Hu H.-M.; Price T.J.; Sirohi B.; KUN-HUEI YEH ; Yang Y.-H.; Sano T.; Yang H.-K.; Zhang X.; Park S.R.; Fujii M.; Kang Y.-K.; Chen L.-T.The Lancet Oncology406263
842013Telomerase-specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic miceLin W.-H.; Shiou-Hwei Yeh ; Yang W.-J.; KUN-HUEI YEH ; Fujiwara T.; Nii A.; Chang S.S.-C.; PEI-JER CHEN International Journal of Cancer2019
852013Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patientsI-CHUN CHEN ; CHIUN HSU ; Chen Y.C.; Chien S.F.; HSIANG-FONG KAO ; Chang S.Y.; Hu F.C.; KUN-HUEI YEH Annals of Oncology3229
862013Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapyWEI-WU CHEN ; CHIA-CHI LIN ; TA-CHEN HUANG ; ANN-LII CHENG ; KUN-HUEI YEH ; CHIH-HUNG HSU Anticancer Research1111
872013High-dose tamoxifen plus ifosfamide and anthracycline in a patient with angiosarcoma of the breastHsiao C.-H.; KUN-HUEI YEH ; Chang Y.-C.; Tsai C.-C.West Indian Medical Journal11
882013Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: Clinical and biological significanceSUNG-HSIN KUO ; Chen L.-T.; CHUNG-WU LIN ; MING-SHIANG WU ; PING-NING HSU ; Tsai H.-J.; Chu C.-Y.; Tzeng Y.-S.; HSIU-PO WANG ; KUN-HUEI YEH ; ANN-LII CHENG Blood Cancer Journal3836
892013ADAR2-mediated editing of miR-214 and miR-122 precursor and antisense RNA transcripts in liver cancersLiu W.-H.; Chen C.-H.; KUN-HUEI YEH ; Li C.-L.; Wu Y.-J.; DING-SHINN CHEN ; PEI-JER CHEN ; Shiou-Hwei Yeh PLoS ONE2418
902013No evidence of IGH-MALT1-translocation in the Ma-1 cell line-A replySUNG-HSIN KUO ; Weng W.-H.; KUN-HUEI YEH ; Chen L.-T.; ANN-LII CHENG Genes Chromosomes and Cancer11
912012KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer CellsLin Y.-L.; JAU-YU LIAU ; SHAN-CHI YU ; DA-LIANG OU ; LIANG-IN LIN ; LI-HUI TSENG ; YIH-LEONG CHANG ; KUN-HUEI YEH ; ANN-LII CHENG PLoS ONE4435
922012Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomasSUNG-HSIN KUO ; KUN-HUEI YEH ; MING-SHIANG WU ; CHUNG-WU LIN ; PING-NING HSU ; HSIU-PO WANG ; Chen L.-T.; ANN-LII CHENG Blood11593
932012Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regressionCHIUN HSU ; Ying-Chun Shen ; Cheng C.-C.; ANN-LII CHENG ; Hu F.-C.; KUN-HUEI YEH Gastric Cancer1918
942012Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancerLI-CHUN LU ; YU-YUN SHAO ; CHIH-HUNG HSU ; CHIUN HSU ; WEN-FANG CHENG ; YU-LIN LIN ; ANN-LII CHENG ; KUN-HUEI YEH Anticancer Research0
952012Estrogen receptor α represses transcription of HBV genes via interaction with hepatocyte nuclear factor 4αWang S.-H.; Shiou-Hwei Yeh ; Lin W.-H.; KUN-HUEI YEH ; Yuan Q.; Xia N.-S.; DING-SHINN CHEN ; PEI-JER CHEN Gastroenterology10695
962011Phase I, pharmacokinetic, and bone marrow drug-level studies of trimonthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancersHo Y.-F.; Lu W.-C.; Chen R.R.-L.; ANN-LII CHENG ; KUN-HUEI YEH Anti-Cancer Drugs53
972011T(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvementSUNG-HSIN KUO ; ANN-LII CHENG ; CHUNG-WU LIN ; CHIH-HUNG HSU ; MING-SHIANG WU ; KUN-HUEI YEH ; Tzeng Y.-S.; Chen L.-T.Cancer Chemotherapy and Pharmacology138
982011Establishment of a novel MALT lymphoma cell line, ma-1, from a patient with t(14;18)(q32;q21)-positive Helicobacter Pylori-independent gastric MALT lymphomaSUNG-HSIN KUO ; Weng W.-H.; Chen Z.-H.; PING-NING HSU ; MING-SHIANG WU ; CHUNG-WU LIN ; Jeng H.-J.; KUN-HUEI YEH ; Tsai H.-J.; Chen L.-T.; ANN-LII CHENG Genes Chromosomes and Cancer79
992011A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in TaiwanChen J.-S.; Chao Y.; Hsieh R.-K.; ANN-LII CHENG ; Chen P.-M.; Chiou T.-J.; Chao T.-Y.; KUN-HUEI YEH ; Chen L.-T.; Whang-Peng J.Cancer Chemotherapy and Pharmacology65
1002011Personality trait and quality of life in colorectal cancer survivorsShun S.-C.; FEI-HSIU HSIAO ; YEUR-HUR LAI ; JIN-TUNG LIANG ; KUN-HUEI YEH ; JOHN HUANG Oncology Nursing Forum1615
1012011Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001SUNG-HSIN KUO ; CHIH-HUNG HSU ; Chen L.-T.; YEN-SHEN LU ; Lin C.-H.; Yeh P.-Y.; Jeng H.-J.; Gao M.; KUN-HUEI YEH ; ANN-LII CHENG European Journal of Cancer1717
1022011Recent advances in the treatment of metastatic colorectal cancer in TaiwanLin Y.-L.; KUN-HUEI YEH ; ANN-LII CHENG Journal of the Formosan Medical Association11
1032011Depletion of β-catenin from mature hepatocytes of mice promotes expansion of hepatic progenitor cells and tumor developmentWang E.-Y.; Shiou-Hwei Yeh ; Tsai T.-F.; HSIANG-PO HUANG ; YUNG-MING JENG ; Lin W.-H.; Chen W.-C.; KUN-HUEI YEH ; PEI-JER CHEN ; Chen D.-S.Proceedings of the National Academy of Sciences of the United States of America3026
1042010Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulationPO-HAN LIN ; YEN-SHEN LU ; CHING-HUNG LIN ; DWANG-YING CHANG ; CHIUN-SHENG HUANG ; ANN-LII CHENG ; KUN-HUEI YEH Anticancer Research64
1052009EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatmentHuang C.-L.; CHIH-HSIN YANG ; KUN-HUEI YEH ; Hu F.-C.; KUAN-YU CHEN ; JIN-YUAN SHIH ; ZHONG-ZHE LIN ; CHONG-JEN YU ; ANN-LII CHENG ; PAN-CHYR YANG Lung Cancer4336
1062008Long-term follow-up of gastrectomized patients with mucosa-associated lymphoid tissue lymphoma: Need for a revisit of surgical treatmentSUNG-HSIN KUO ; Chen L.-T.; MING-SHIANG WU ; CHUNG-WU LIN ; KUN-HUEI YEH ; KUAN-TING KUO ; Yeh P.-Y.; Tzeng Y.-S.; HSIU-PO WANG ; PING-NING HSU ; Lin J.-T.; ANN-LII CHENG Annals of Surgery1413
1072008Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cellsChen K.-F.; Yeh P.-Y.; KUN-HUEI YEH ; YEN-SHEN LU ; SHANG-YI HUANG ; ANN-LII CHENG Cancer Research114105
1082008Weekly 24-hour infusional 5-fluorouracil as initial treatment for advanced gastric cancer with acute disseminated intravascular coagulationTA-CHEN HUANG ; KUN-HUEI YEH ; ANN-LII CHENG ; CHIH-HUNG HSU Anticancer Research159
1092008Overexpression of B cell activating factor of TNF family (BAFF) is associated with Helicobacter pylori independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphomaSUNG-HSIN KUO ; Yeh P.-Y.; Chen L.-T.; MING-SHIANG WU ; CHUNG-WU LIN ; KUN-HUEI YEH ; Tzeng Y.-S.; Chen J.-Y.; PING-NING HSU ; Lin J.-T.; ANN-LII CHENG Blood4647
1102007Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancerCHIA-CHI LIN ; CHIH-HUNG HSU ; CHIA-HSIEN CHENG ; HSIU-PO WANG ; JANG-MING LEE ; KUN-HUEI YEH ; CHIH-HSIN YANG ; Lin J.-T.; ANN-LII CHENG ; Lee Y.-C.Annals of Oncology3936
1112007Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinomaCHIA-CHI LIN ; KUN-HUEI YEH ; CHIH-HSIN YANG ; CHIUN HSU ; YU-CHIEH TSAI ; Hsu W.-L.; ANN-LII CHENG ; CHIH-HUNG HSU Anti-Cancer Drugs108
1122007Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach - Significance of tumour cell clonality and BCL10 expressionSUNG-HSIN KUO ; Chen L.-T.; MING-SHIANG WU ; KUAN-TING KUO ; KUN-HUEI YEH ; SHIN-LIAN DOONG ; Yeh P.-Y.; Hsu H.-C.; Tzeng Y.-S.; CHUNG-WU LIN ; Lin J.-T.; ANN-LII CHENG Journal of Pathology1911
1132007A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancerCHIA-CHI LIN ; ANN-LII CHENG ; CHIH-HUNG HSU ; YEN-SHEN LU ; CHIUN HSU ; KUN-HUEI YEH ; Wu C.-Y.; CHIUN-SHENG HUANG ; CHIH-HSIN YANG Anticancer Research22
1142006Disseminated Mycobacterium kansasii infection in an HIV-negative patient presenting with mimicking multiple bone metastasesTsai C.-W.; JANN-TAY WANG ; Tsai C.-C.; KUN-HUEI YEH Diagnostic Microbiology and Infectious Disease85
1152006An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancerChao Y.; Li C.P.; Chao T.Y.; Su W.C.; Hsieh R.K.; Wu M.F.; KUN-HUEI YEH ; Kao W.Y.; Chen L.T.; ANN-LII CHENG British Journal of Cancer1313
1162006A pathway for tumor necrosis factor-α-induced Bcl10 nuclear translocation: Bcl10 is up-regulated by NF-κB and phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleusPei Y.Y.; SUNG-HSIN KUO ; KUN-HUEI YEH ; Chuang S.-E.; CHIH-HUNG HSU ; Wen C.C.; Lin H.-I.; Gao M.; ANN-LII CHENG Journal of Biological Chemistry4339
1172005Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21)KUN-HUEI YEH ; SUNG-HSIN KUO ; Chen, Li-Tzong; TSUI-LIEN MAO ; SHIN-LIAN DOONG ; MING-SHIANG WU ; Hsu, Hui-Chen; Tzeng, Yi-Shin; Chen, Chi-Long; JAW-TOWN LIN ; ANN-LII CHENG Blood7159
1182005Expression of CD86 and increased inflitration of NK cells are associated with Helicobacter pylori-dependent state of early stage high-grade gastric MALT lymphomaSUNG-HSIN KUO ; Chen L.-T.; Chen C.-L.; SHIN-LIAN DOONG ; KUN-HUEI YEH ; MING-SHIANG WU ; TSUI-LIEN MAO ; Hsu H.-C.; HSIU-PO WANG ; Lin J.-T.; ANN-LII CHENG World Journal of Gastroenterology1515
1192005Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancerKUN-HUEI YEH ; YEN-SHEN LU ; CHIH-HUNG HSU ; Lin J.F.; Chao H.J.; Ta-Chen Huang ; Chung C.Y.; Chang C.S.; CHIH-HSIN YANG ; ANN-LII CHENG British Journal of Cancer77
1202005Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptorsYEN-SHEN LU ; HUANG-CHUN LIEN ; Yeh P.-Y.; KUN-HUEI YEH ; Kuo M.-L.; SUNG-HSIN KUO ; ANN-LII CHENG World Journal of Gastroenterology2625
1212005Somatic mutations in epidermal growth factor receptor underlying complete responsiveness to gefitinib in a Taiwanese female patient with metastatic adenocarcinoma of lungKUN-HUEI YEH ; Shiou-Hwei Yeh ; Wan J.-P.; Ying-Chun Shen ; ANN-LII CHENG Anti-Cancer Drugs43
1222005Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatmentCHIH-HSIN YANG ; Chen M.-C.; ANN-LII CHENG ; CHIH-HUNG HSU ; KUN-HUEI YEH ; Yu Y.-C.; Whang-Peng J.; PAN-CHYR YANG Oncology54
1232005Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancerKUN-HUEI YEH ; YEN-SHEN LU ; CHIH-HUNG HSU ; Lin J.-F.; CHIUN HSU ; SUNG-HSIN KUO ; Li Jr. S.; ANN-LII CHENG Oncology2222
1242004Down-regulation of thymidylate synthase expression and its steady-state mRNA by oxaliplatin in colon cancer cellsKUN-HUEI YEH ; ANN-LII CHENG ; Wan J.-P.; Lin C.-S.; Liu C.-C.Anti-Cancer Drugs3733
1252004Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tractCHIUN HSU ; Ying-Chun Shen ; CHIH-HSIN YANG ; KUN-HUEI YEH ; YEN-SHEN LU ; CHIH-HUNG HSU ; Liu H.-T.; Li C.-C.; Chen J.-S.; Wu C.-Y.; ANN-LII CHENG British Journal of Cancer4240
1262004Recent advances in therapy for gastric cancerKUN-HUEI YEH ; ANN-LII CHENG Journal of the Formosan Medical Association77
1272004Phase II study of combination doxorubicin, interferon-α, and high-dose tamoxifen treatment for advanced hepatocellular carcinomaLu Y.-S.; CHIUN HSU ; Li C.-C.; Kuo S.-H.; KUN-HUEI YEH ; CHIH-HSIN YANG ; CHIH-HUNG HSU ; Wu C.-Y.; ANN-LII CHENG Hepato-Gastroenterology1413
1282004Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomasSUNG-HSIN KUO ; Chen L.-T.; KUN-HUEI YEH ; MING-SHIANG WU ; Hsu H.-C.; Yeh P.-Y.; TSUI-LIEN MAO ; Chen C.-L.; SHIN-LIAN DOONG ; Lin J.-T.; ANN-LII CHENG Journal of Clinical Oncology6353
1292004Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancerChao Y.; KUN-HUEI YEH ; Chang C.J.; Chen L.T.; Chao T.Y.; Wu M.F.; Chang C.S.; Chang J.Y.; Chung C.Y.; Kao W.Y.; Hsieh R.K.; ANN-LII CHENG British Journal of Cancer7263
1302004Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-κB activation by protein phosphatase 4-mediated NF-κB p 65 Thr dephosphorylationYeh P.Y.; KUN-HUEI YEH ; Chuang S.-E.; Song Y.C.; ANN-LII CHENG Journal of Biological Chemistry9690
1312004Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell deathYeh P.Y.; Chuang S.-E.; KUN-HUEI YEH ; Song Y.C.; Chang L.L.-Y.; ANN-LII CHENG Oncogene7169
1322003High-dose Tamoxifen Modulates Drug Resistance to Doxorubicin, Dacarbazine and Ifosfamide in Metastatic Uterine LeiomyosarcomaKUN-HUEI YEH ; YEN-SHEN LU ; Hsiao C.-H.; ANN-LII CHENG Anticancer Research33
1332003Involvement of nuclear transcription factor-κB in low-dose doxorubicin-induced drug resistance of cervical carcinoma cellsYeh P.Y.; Chuang S.-E.; KUN-HUEI YEH ; Song Y.C.; ANN-LII CHENG Biochemical Pharmacology3731
1342002High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resectionJIN-TUNG LIANG ; KUO-CHIN HUANG ; HONG-SHIEE LAI ; PO-HUANG LEE ; Cheng Y.-M.; Hsu H.-C.; ANN-LII CHENG ; CHIH-HUNG HSU ; KUN-HUEI YEH ; Wang S.-M.; Tang C.; KING-JEN CHANG International Journal of Cancer10998
1352002P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resectionJIN-TUNG LIANG ; KUO-CHIN HUANG ; Cheng Y.-M.; Hsu H.-C.; ANN-LII CHENG ; CHIH-HUNG HSU ; KUN-HUEI YEH ; Wang S.-M.; KING-JEN CHANG International Journal of Cancer6657
1362002Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NFκB activationYeh P.Y.; Chuang S.-E.; KUN-HUEI YEH ; Song Y.C.; Ea C.-K.; ANN-LII CHENG Biochemical Pharmacology130128
1372002A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracilCHIH-HUNG HSU ; ANN-LII CHENG ; CHIUN HSU ; CHIH-HSIN YANG ; YEN-SHEN LU ; CHIA-CHI LIN ; Bu C.-F.; KUN-HUEI YEH Anticancer Research1212
1382002Combination of 13-cis retinoic acid and interferon-α in the treatment of recurrent or refractory peripheral T-cell lymphomaHuang C.-L.; ZHONG-ZHE LIN ; Su I.-J.; Chao T.-Y.; HWEI-FANG TIEN ; Chang M.-C.; Huang M.-C.; Kao W.-Y.; JIH-LUH TANG ; KUN-HUEI YEH ; Wang C.-H.; CHIH-HUNG HSU ; Liu M.-Y.; ANN-LII CHENG Leukemia and Lymphoma95
1392001The F-box protein SKP2 binds to the phosphorylated threonine 380 in cyclin E and regulates ubiquitin-dependent degradation of cyclin EKUN-HUEI YEH ; Kondo T.; Zheng J.; Tsvetkov L.M.; Blair J.; Zhang H.Biochemical and Biophysical Research Communications4849
1402001Nuclear extracellular signal-regulated kinase 2 phosphorylates p53 at Thr55 in response to doxorubicinYeh P.Y.; Chuang S.-E.; KUN-HUEI YEH ; Chyi Song Y.; ANN-LII CHENG Biochemical and Biophysical Research Communications3435
1412000Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracilKUN-HUEI YEH ; Shiou-Hwei Yeh ; CHIH-HUNG HSU ; TONG-MEI WANG ; Ma I.-F.; ANN-LII CHENG British Journal of Cancer26
1422000Minimal toxicity to myeloid progenitor cells of weekly 24-hr infusion of high-dose 5-fluorouracil: Direct evidence from colony forming unit- granulocyte and monocyte (CFU-GM) clonogenic assayKUN-HUEI YEH ; Shiou-Hwei Yeh ; Chang Y.-S.; ANN-LII CHENG Pharmacology and Toxicology1512
1431999p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27Tsvetkov L.M.; KUN-HUEI YEH ; Lee S.-J.; Sun H.; Zhang H.Current Biology698674
1441999Quiescent nasal T/NK cell lymphoma manifested as primary central nervous system lymphomaKUN-HUEI YEH ; HUANG-CHUN LIEN ; Hsu S.-M.; ANN-LII CHENG American Journal of Hematology31
1451999Concurrent chemoradiotherapy for locally advanced esophageal cancer - A pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracilCHIH-HUNG HSU ; KUN-HUEI YEH ; Lui L.T.; Lee Y.-C.; Bu C.-F.; HSIU-PO WANG ; Lin J.-T.; ANN-LII CHENG Anticancer Research2926
1461999Overexpression of p53 is not associated with drug resistance of gastric cancers to 5-fluorouracil-based systemic chemotherapyKUN-HUEI YEH ; CHIA-TUNG SHUN ; Chen C.-L.; Lin J.-T.; Lee W.-J.; PO-HUANG LEE ; YAO-CHANG CHEN ; ANN-LII CHENG Hepato-Gastroenterology2324
1471999High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinomaCHIH-HSIN YANG ; ANN-LII CHENG ; KUN-HUEI YEH ; CHONG-JEN YU ; Lin J.-F.; PAN-CHYR YANG Cancer23
1481998Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: A pilot study of the BOMES protocolANN-LII CHENG ; KUN-HUEI YEH ; Uen W.-C.; Hung R.-L.; Liu M.-Y.; Wang C.-H.Cancer61
1491998High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapyKUN-HUEI YEH ; CHIA-TUNG SHUN ; Chen C.-L.; Lin J.-T.; Lee W.-J.; PO-HUANG LEE ; YAO-CHANG CHEN ; ANN-LII CHENG Cancer105
1501998Nasal septal tumor as a sole presentation in the head and neck region in Rosai-Dorfman diseaseSheen T.-S.; YIH-LEONG CHANG ; KUN-HUEI YEH ; CHEN-TU WU ; JENG-YUH KO Otolaryngology - Head and Neck Surgery77
1511998Gastric cancer associated with acute disseminated intravascular coagulation: Successful initial treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorinKUN-HUEI YEH ; ANN-LII CHENG British Journal of Haematology4035
1521998Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifenANN-LII CHENG ; Chuang S.-E.; Fine R.L.; KUN-HUEI YEH ; Liao C.-M.; Lay J.-D.; Chen D.-S.Biochemical Pharmacology6965
1531998Encephalopathy, lactic acidosis, hyperammonaemia and 5-fluorouracil toxicity (multiple letters) [1]Valik D.; KUN-HUEI YEH ; ANN-LII CHENG British Journal of Cancer35
1541998Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 (K19) - Possible clinical significance in advanced gastric cancerKUN-HUEI YEH ; YAO-CHANG CHEN ; Shiou-Hwei Yeh ; Chen C.-P.; Lin J.-T.; ANN-LII CHENG Anticancer Research4643
1551998T-cell malignant lymphoma with conjunctival involvementFUNG-RONG HU ; Lin J.-C.; Chiang I.-P.; KUN-HUEI YEH American Journal of Ophthalmology1312
1561998Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinomaANN-LII CHENG ; KUN-HUEI YEH ; Fine R.L.; Chuang S.-E.; Yang C.-H.; Wang L.-H.; DING-SHINN CHEN Hepato-Gastroenterology4133
1571998High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancersKUN-HUEI YEH ; Lin M.-T.; Lin D.-T.; JIH-LUH TANG ; Lui L.-T.; Lin J.-F.; Chang Y.-S.; ANN-LII CHENG ; Yu S.-C.; KING-JEN CHANG ; YAO-CHANG CHEN Breast Cancer Research and Treatment22
1581998Relatively low expression of multidrug resistance-1 (MDR-1) and its possible clinical implication in gastric cancersKUN-HUEI YEH ; Chen C.-L.; CHIA-TUNG SHUN ; Lin J.-T.; Lee W.-J.; PO-HUANG LEE ; YAO-CHANG CHEN ; ANN-LII CHENG Journal of Clinical Gastroenterology1512
1591998Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL) - A very effective regimen with good patients' compliance for advanced gastric cancerANN-LII CHENG ; KUN-HUEI YEH ; Lin J.-T.; CHIUN HSU ; Liu M.-Y.Anticancer Research2320
1601997MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancerCHIUN HSU ; KUN-HUEI YEH ; RUEY-LONG HONG ; CHIH-HSIN YANG ; Lin M.-T.; YAO-CHANG CHEN ; ANN-LII CHENG Journal of the Formosan Medical Association43
1611997A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancersKUN-HUEI YEH ; ANN-LII CHENG ; Lin M.-T.; RUEY-LONG HONG ; CHIH-HUNG HSU ; Lin J.-F.; KING-JEN CHANG ; PO-HUANG LEE ; YAO-CHANG CHEN Anticancer Research3227
1621997Thymic carcinoma with autoimmune syndrome: Successful treatment with weekly infusional high-dose 5-fluorouracil and leucovorinCHIH-HUNG HSU ; KUN-HUEI YEH ; ANN-LII CHENG Anticancer Research1817
1631997High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy [2]KUN-HUEI YEH ; ANN-LII CHENG British Journal of Cancer12497
1641997High-dose tamoxifen reverses drug resistance to cisplatin and etoposide in a patient with advanced large cell carcinoma of lungKUN-HUEI YEH ; ANN-LII CHENG Anticancer Research1411
1651997Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of advanced gastric cancersCHIH-HUNG HSU ; KUN-HUEI YEH ; Chen L.-T.; Liu J.M.; Jan C.-M.; Lin J.-T.; YAO-CHANG CHEN ; ANN-LII CHENG Oncology (Switzerland)6051
1661997Prognostic significance of immunophenotypes in adult lymphoblastic lymphomasKUN-HUEI YEH ; ANN-LII CHENG ; Su I.H.-J.; Lin M.-T.; HWEI-FANG TIEN ; MING-CHING SHEN ; Wang C.-H.; YAO-CHANG CHEN Anticancer Research2014
1671996Chronic oral etoposide and tamoxifen in the treatment of far-advanced hepatocellular carcinomaANN-LII CHENG ; YAO-CHANG CHEN ; KUN-HUEI YEH ; Chuang S.-E.; Chen B.-R.; DING-SHINN CHEN Cancer37
1681995Long-term disease-free survival after autologous bone marrow transplantation in a primary plasma cell leukaemia: detection of minimal residual disease in the transplant marrow by third-complementarity-determining region-specific probesKUN-HUEI YEH ; Lin M. T.; JIH-LUH TANG ; CHIH-HSIN YANG ; WOEI TSAY ; YAO-CHANG CHEN British Journal of Haematology1914
1691995Primary T cell leptomeningeal lymphoma – Successful treatment with systemic chemotherapyKUN-HUEI YEH ; ANN-LII CHENG ; HWEI-FANG TIEN Oncology (Switzerland)149
1701994An alternative method to overcome central venous portable external infusion pump blockage in patients receiving weekly 24-hour high-dose fluorouracil and leucovorin [2]KUN-HUEI YEH ; ANN-LII CHENG Journal of Clinical Oncology1816
1711994Panhypopituitarism caused by solitary parasellar metastasis from lung cancerJEN-CHANG KO ; PAN-CHYR YANG ; TIEN-SHANG HUANG ; KUN-HUEI YEH ; Kuo S.-H.; KWEN-TAY LUH Chest1917
1721994Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantationCHIEN-HUNG CHEN ; PEI-JER CHEN ; Chu J.-S.; KUN-HUEI YEH ; Lai M.-Y.; DING-SHINN CHEN Gastroenterology6955
1731994Acute confusion induced by a high-dose infusion of 5-fluorouracil and folinic acidKUN-HUEI YEH ; ANN-LII CHENG Journal of the Formosan Medical Association160
1741994Severe isolated acute hepatic graft-versus-host disease with vanishing bile duct syndromeKUN-HUEI YEH ; Hsieh H.-C.; JIH-LUH TANG ; Lin M.-T.; CHIH-HSIN YANG ; YAO-CHANG CHEN Bone Marrow Transplantation2111
1751994Five-drug combination chemotherapy (FAPEL) for advanced gastric cancer: A pilot studyKUN-HUEI YEH ; ANN-LII CHENG ; Chen Y.-C.; Chen B.-R.; Lee W.-J.; Lin J.-T.; PO-HUANG LEE ; KING-JEN CHANG ; Wang C.-H.; Wang T.-H.Journal of the Formosan Medical Association60